- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-RPL22
RPL22 Polyclonal Antibody for WB, IP, IF, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (1)
Applications
WB, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 25002-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A431, cellules HeLa, cellules HepG2, cellules Jurkat |
Résultats positifs en IP | cellules A431, |
Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 8 publications below |
IF | See 2 publications below |
IP | See 1 publications below |
Informations sur le produit
25002-1-AP cible RPL22 dans les applications de WB, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | RPL22 Protéine recombinante Ag21851 |
Nom complet | ribosomal protein L22 |
Masse moléculaire calculée | 15 kDa |
Poids moléculaire observé | 15-18 kDa |
Numéro d’acquisition GenBank | BC058887 |
Symbole du gène | RPL22 |
Identification du gène (NCBI) | 6146 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Protocole
Product Specific Protocols | |
---|---|
WB protocol for RPL22 antibody 25002-1-AP | Download protocol |
IF protocol for RPL22 antibody 25002-1-AP | Download protocol |
IP protocol for RPL22 antibody 25002-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Acta Neuropathol Commun Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease | ||
Cell Death Discov N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness | ||
Carcinogenesis The Molecular Landscape of Synchronous Colorectal Cancer Reveals Genetic Heterogeneity. | ||
Mol Neurobiol Exosomes Derived from Meningitic Escherichia coli-Infected Brain Microvascular Endothelial Cells Facilitate Astrocyte Activation | ||
Cell Cycle Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
|
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Yuki (Verified Customer) (01-14-2021) | Cells were grown on sterile coverslips embedded in a 6-well plate. Cells were fixed with 3.7% paraformaldehyde and permeabilized with 0.2% Triton X-100. After blocking with 2% goat serum in PBS, the protein was detected using anti-PRL22 antibodies followed by reaction with Alexa Fluor488- conjugated secondary antibodies.
|